Helios Software (PRIVATE.HELIOS)

Overall impact
B (73)

Commentary

Helios Software is a strong overall performer. With a 'B' rating of 72.8 for overall impact (86th percentile compared to all companies), Helios Software ranks 17th out of 96 industry peers, behind Healthequity, CareCloud, Brainsway and 13 others, and ahead of Suvoda, Gainwell Technologies, Maximus and 76 others. On top material causes for Helios Software's industry (Healthcare Software & Services), Helios Software performs well in Reduced Use of tobacco (96.2 score), Disaster Readiness and Effective Aid (84.7), Child and Maternal Health (93.9) and 4 other causes where it received an 'A' score and performs poorly in Fair Labor Practices (25.6 score).
Company
Founded
2016
Employees
4
Sector
Health Care
Industry
Software
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
Massachusetts, United States
Share classes
PRIVATE.HELIOS
Helios Software
Description
Helios Software is a Boston-based health technology company dedicated to making HL7® FHIR® accessible for health organizations. Helios offers the Helios FHIR Server, a commercial-grade, clinical data solution based on the HL7® FHIR® standard. Our server uniquely runs on Apache Cassandra™, a fault-tolerant, high availability, distributed database designed for mission-critical data. In addition to offering the Helios FHIR Server, we also provide training and consulting services for organizations who need help along their FHIR journey. Feel free to reach out to us at our website, or join our LinkedIn Group for all things FHIR.
Material causes
Ethos considers the following causes material for Helios Software, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.